Our latest updates:
Members of the PROGRESS research group were involved in the successful proposal to the European Medicines Agency to relax the haematological monitoring requirements for clozapine.
The PROGRESS research group has developed the first sex-specific guideline for the choice of first antipsychotic medication for females with a first episode of psychosis.
People living with severe mental illness (SMI) experience a shorter life expectancy and poorer physical health than those without SMI. Cardiometabolic illness accounts for a
In this invited commentary, we expand upon the findings of DelBello and Colleagues, who published a trial demonstrating that metformin was effective in mitigating weight
We are delighted to announce that the article: 'Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation' won the best Research Paper/
